cancer immunotherapy
Cancer Be Damned
Cancer Be Damned
Bob Grant | Apr 1, 2016
Teenager Lauren Bendesky turned her cancer diagnosis on its head, using herself as a research subject to test potential therapies.
Week in Review: November 2–6
Week in Review: November 2–6
Jef Akst | Nov 6, 2015
How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators
Microbes Play Role in Anti-Tumor Response
Microbes Play Role in Anti-Tumor Response
Anna Azvolinsky | Nov 5, 2015
Gut microbiome composition can influence the effectiveness of cancer immunotherapy in mice.
CAR-T Therapies Get $1 Billion Boost
CAR-T Therapies Get $1 Billion Boost
Bob Grant | Jul 1, 2015
The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Jacob Richards | Apr 22, 2015
T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Yvonne Saenger: Immunotherapy Pioneer
Yvonne Saenger: Immunotherapy Pioneer
Jef Akst | Apr 1, 2015
Assistant Professor, Department of Medicine, Columbia University. Age: 41
The CAR T-Cell Race
The CAR T-Cell Race
Vicki Brower | Apr 1, 2015
Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.
Cancer Immunotherapist
Cancer Immunotherapist
Jef Akst | Apr 1, 2015
Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.
Opinion: Making Cancer Vaccines Work
Opinion: Making Cancer Vaccines Work
Abhishek Srivastava and Haval Shirwan | Mar 31, 2015
Armed with the right adjuvant system, vaccines are poised to tackle one of the world’s most intractable diseases.